Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for 200mm and 250mm lengths of the In.Pact Admiral Drug-Coated Balloon (DCB) to treat long superficial femoral artery (...
Drug-Eluting Balloons
This channel includes news and new technology innovations for drug coated balloons, also referred to as drug-eluting balloons. These are used to treat peripheral and coronary artery lesions and restenosis.
-
-
C.R. Bard Inc. announced the Lutonix 035 Drug Coated Balloon PTA Catheter (DCB) has been granted premarket approval (PMA) by the U.S. Food and Drug Administration (FDA) for a new indication. With...
-
The Spectranetics Corp. announced receipt of U.S. Food and Drug Administration (FDA) pre-market approval (PMA) of the Stellarex drug-coated balloon (DCB). The device is designed to restore and...
-
Philips Healthcare and Spectranetics Corp. announced they have entered into a definitive merger agreement for $2.05 billion. The acquisition of Spectranetics will further expand and strengthen...
Technology | Drug-Eluting Balloons | June 15, 2018
June 15, 2018 — Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for 200mm and 250mm...
News | Drug-Eluting Balloons | May 29, 2018
May 29, 2018 – M.A. MedAlliance SA has raised $37 million to help develop and commercialize the first sirolimus...
Technology | Drug-Eluting Balloons | May 03, 2018
May 3, 2018 — The U.S. Food and Drug Administration (FDA) has expanded the indication for the Medtronic In.Pact ...
News | Drug-Eluting Balloons | February 07, 2018
February 7, 2018 — Medtronic plc recently added to its body of clinical evidence supporting the In.Pact Admiral...
An illustration of the Sequent Please drug-coated balloon.
Feature | Drug-Eluting Balloons | November 02, 2017
November 2, 2017 — The treatment of in-stent restenosis (ISR) remains challenging in clinical practice. The DARE (...
News | Drug-Eluting Balloons | September 18, 2017
September 18, 2017 — Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (...
News | Peripheral Artery Disease (PAD) | September 13, 2017
September 13, 2017 — Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual...
News | Drug-Eluting Balloons | September 13, 2017
September 13, 2017 — Medtronic plc announced that the In.Pact Admiral...
Technology | Drug-Eluting Balloons | August 29, 2017
August 29, 2017 — C.R. Bard Inc. announced the Lutonix 035...
News | Drug-Eluting Balloons | August 15, 2017
August 15, 2017 — Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food...
Technology | Drug-Eluting Balloons | July 26, 2017
July 26, 2017 — The Spectranetics Corp. announced receipt of U.S. Food and Drug Administration (FDA) pre-market...
News | June 12, 2017
June 12, 2017 – Med Alliance announced completion on schedule of patient enrollment in the first-in-man (FIM) study...
News | Drug-Eluting Balloons | April 26, 2017
April 26, 2017 — Boston Scientific announced results from the RANGER SFA trial for the Ranger Paclitaxel-Coated PTA...
News | Peripheral Artery Disease (PAD) | March 09, 2017
March 9, 2017 — Medtronic plc announced the launch of the IN.PACT BTK study to evaluate the effectiveness of a...
